Baxter Keeps Trade Secret Claims In HQ Arrhythmia Drug Suit
A New Jersey judge has allowed Baxter Healthcare Corp. to pursue allegations that HQ Specialty Pharma Corp. misappropriated trade secrets in developing a generic version of anti-arrhythmia drug Brevibloc, maintaining certain...To view the full article, register now.
Already a subscriber? Click here to view full article